Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/267
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKovacs, Gaben
dc.date.accessioned2015-07-02T04:00:13Zen
dc.date.available2015-07-02T04:00:13Zen
dc.date.issued2015-06en
dc.identifier.urihttp://hdl.handle.net/11434/267en
dc.description.abstractPoster presentation. Objective: To evaluate studies reporting on the use of steroids, intravenous immunoglobulin (IVIg) ,andintralipid (IL) therapies to determine if they can improve implantation ,clinical pregnancy, and live birth rates. Conclusion: There is no strong evidence supporting the use of steroid and IVIg therapies to improve IVF outcomes.en
dc.subjectObstetrics and Gynaecology Clinical Institute, Epworth HealthCare, Victoria, Australiaen
dc.subjectSteriodsen
dc.subjectInfertilityen
dc.subjectIntralipid (IL) Therapiesen
dc.subjectAssisted Reproductive Technique (ART)en
dc.subjectIn Vitro Fertilization (IVF)en
dc.subjectIntravenous Immunoglobulin (IVIg)en
dc.subjectImplantationen
dc.subjectLive Birth Rateen
dc.subjectClinical Pregnancy Rateen
dc.subjectPoster Presentationen
dc.titleSteroid, IVIg, and intralipid therapies for IVF.en
dc.typeConference Paperen
dc.description.affiliatesThe University of Melbourne, Faculty of Medicineen
dc.description.affiliatesMonash University Department of Obstetrics and Gynecologyen
dc.type.studyortrialSystematic Reviewsen
dc.description.conferencenameEpworth Research Institute. Research Week June 2015.en
dc.description.conferencelocationEpworth Hospital, Richmond, Victoria, Australia.en
dc.type.contenttypeImageen
Appears in Collections:Research Week
Women's and Children's

Files in This Item:
File Description SizeFormat  
Poster_Vega Andhira.pdf357.44 kBAdobe PDFView/Open


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.